Prevention and Treatment of Pregnancy-Associated Hypertension: What Have We Learned in the Last 10 Years?
- 1 September 1991
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 18 (3) , 285-305
- https://doi.org/10.1016/s0272-6386(12)80087-4
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced HypertensionNew England Journal of Medicine, 1989
- The Use of Aspirin to Prevent Ppregnancy-Induced Hypertension and Lower the Ratio of Thromboxane A2to Prostcyclin in Relatively High Risk PregnanciesNew England Journal of Medicine, 1989
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- Hypocalciuria in PreeclampsiaNew England Journal of Medicine, 1987
- Short-Term Neonatal Morbidity Associated with Prematurity and the Effect of a Prematurity Prevention Program on Expected Incidence of MorbidityAmerican Journal of Perinatology, 1986
- Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolitesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- CARDIOPULMONARY ARREST DUE TO ACUTE MATERNAL HYPERMAGNESAEMIAThe Lancet, 1981
- Clinical Pharmacology of Labetalol in PregnancyJournal of Cardiovascular Pharmacology, 1981
- PROSTACYCLIN ACTIVITY IN AMNIOTIC FLUID IN PRE-ECLAMPSIAThe Lancet, 1980
- A double blind placebo controlled crossover study of prostacyclin in manLife Sciences, 1979